A. S. Anastasia, “Clinical characteristics, serum albumin and eosinophil levels as risk factors for drug induced hepatitis in tuberculosis patients receiving fixed-dose combination anti-tuberculosis drug”, Int J Adv Med, vol. 9, no. 4, pp. 399–404, Mar. 2022.